UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficient and Selective AAV2-Mediated Gene Transfer Directed to Human Vascular Endothelial Cells

Molecular therapy, 2001-09, Vol.4 (3), p.174-181

2001

Volltextzugriff (PDF)

Oncogenesis Following Delivery of a Nonprimate Lentiviral Gene Therapy Vector to Fetal and Neonatal Mice

Molecular therapy, 2005-10, Vol.12 (4), p.763-771

2005

Volltextzugriff (PDF)

AAV-Mediated gene transfer slows photoreceptor loss in the RCS rat model of retinitis pigmentosa

Molecular therapy, 2003-08, Vol.8 (2), p.188-195

2003

Volltextzugriff (PDF)

A Partial Down-regulation of WASP Is Sufficient to Inhibit Podosome Formation in Dendritic Cells

Molecular therapy, 2006-04, Vol.13 (4), p.729-737

2006

Volltextzugriff (PDF)

Local Administration of an Adeno-associated Viral Vector Expressing IL-10 Reduces Monocyte Infiltration and Subsequent Photoreceptor Damage during Experimental Autoimmune Uveitis

Molecular therapy, 2005-08, Vol.12 (2), p.369-373

2005

Volltextzugriff (PDF)

Comparison of HIV- and EIAV-Based Vectors on Their Efficiency in Transducing Murine and Human Hematopoietic Repopulating Cells

Molecular therapy, 2005-09, Vol.12 (3), p.537-546

2005

Volltextzugriff (PDF)

Evolving Gene Therapy in Primary Immunodeficiency

Molecular therapy, 2017-05, Vol.25 (5), p.1132-1141

2017

Volltextzugriff (PDF)

Insertional Transformation of Hematopoietic Cells by Self-inactivating Lentiviral and Gammaretroviral Vectors

Molecular therapy, 2009-11, Vol.17 (11), p.1919-1928

2009

Volltextzugriff (PDF)

Gene Therapy of Chronic Granulomatous Disease: The Engraftment Dilemma

Molecular therapy, 2011-01, Vol.19 (1), p.28-35

2011

Volltextzugriff (PDF)

Predicting genotoxicity of viral vectors for stem cell gene therapy using gene expression-based machine learning

Molecular therapy, 2021-12, Vol.29 (12), p.3383-3397

2021

Volltextzugriff (PDF)

Preclinical Demonstration of Lentiviral Vector-mediated Correction of Immunological and Metabolic Abnormalities in Models of Adenosine Deaminase Deficiency

Molecular therapy, 2014-03, Vol.22 (3), p.607-622

2014

Volltextzugriff (PDF)

A Ubiquitous Chromatin Opening Element (UCOE) Confers Resistance to DNA Methylation–mediated Silencing of Lentiviral Vectors

Molecular therapy, 2010-09, Vol.18 (9), p.1640-1649

2010

Volltextzugriff (PDF)

Self-inactivating Gammaretroviral Vectors for Gene Therapy of X-linked Severe Combined Immunodeficiency

Molecular therapy, 2008-03, Vol.16 (3), p.590-598

2008

Volltextzugriff (PDF)

Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplant

Molecular therapy, 2024-06, Vol.32 (6), p.1672-1686

2024

Volltextzugriff (PDF)

A New Chapter on Targeted Gene Insertion for X-CGD: Do Not Skip the Intro(n)

Molecular therapy, 2017-02, Vol.25 (2), p.307-309

2017

Volltextzugriff (PDF)

Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-free Approach

Molecular therapy, 2024-08, Vol.32 (8), p.2798-2798

2024

Volltextzugriff (PDF)

Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-free Approach

Molecular therapy, 2012-10, Vol.20 (10), p.1953-1967

2012

Volltextzugriff (PDF)

Successful Reconstitution of Immunity in ADA-SCID by Stem Cell Gene Therapy Following Cessation of PEG-ADA and Use of Mild Preconditioning

Molecular therapy, 2006-10, Vol.14 (4), p.505-513

2006

Volltextzugriff (PDF)

Biochemical Correction of X-CGD by a Novel Chimeric Promoter Regulating High Levels of Transgene Expression in Myeloid Cells

Molecular therapy, 2011-01, Vol.19 (1), p.122-132

2011

Volltextzugriff (PDF)

Stable Gene Transfer to Muscle Using Non-integrating Lentiviral Vectors

Molecular therapy, 2007-11, Vol.15 (11), p.1947-1954

2007

Volltextzugriff (PDF)

Perforin Gene Transfer Into Hematopoietic Stem Cells Improves Immune Dysregulation in Murine Models of Perforin Deficiency

Molecular therapy, 2015-04, Vol.23 (4), p.737-745

2015

Volltextzugriff (PDF)

“Darwinian” Tumor-Suppression Model Unsupported in Clinical Experience

Molecular therapy, 2014-09, Vol.22 (9), p.1562-1563

2014

Volltextzugriff (PDF)

Correction of Murine Rag2 Severe Combined Immunodeficiency by Lentiviral Gene Therapy Using a Codon-optimized RAG2 Therapeutic Transgene

Molecular therapy, 2012-10, Vol.20 (10), p.1968-1980

2012

Volltextzugriff (PDF)

“Special Exemptions”: Should They Be Put on Trial?

Molecular therapy, 2013-02, Vol.21 (2), p.261-262

2013

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieMolecular Therapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(62)

Sprache

Englisch
(62)

Erscheinungsjahr

n.n

Thema

Biotechnology & Applied Microbiology
(43)
Gene Therapy
(43)
Genetics & Heredity
(43)
Life Sciences & Biomedicine
(43)
Medicine, Research & Experimental
(43)
Research & Experimental Medicine
(43)
Science & Technology
(43)
Humans
(32)
Vectors
(32)
Animals
(25)
Mice
(23)
Immunology
(22)
Stem Cells
(21)
Lentivirus - Genetics
(20)
Gene Expression
(19)
Original
(19)
Genetic Vectors - Genetics
(16)
Childrens Health
(15)
Genetic Therapy - Methods
(15)
Mutagenesis
(14)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Menü

Weitere Dienste

Einstellungen

Efficient and Selective AAV2-Mediated Gene Transfer Directed to Human Vascular Endothelial Cells

Stem Cell Gene Therapy for Fanconi Anemia: Report from the 1st International Fanconi Anemia Gene Therapy Working Group Meeting

Oncogenesis Following Delivery of a Nonprimate Lentiviral Gene Therapy Vector to Fetal and Neonatal Mice

AAV-Mediated gene transfer slows photoreceptor loss in the RCS rat model of retinitis pigmentosa

A Partial Down-regulation of WASP Is Sufficient to Inhibit Podosome Formation in Dendritic Cells

Local Administration of an Adeno-associated Viral Vector Expressing IL-10 Reduces Monocyte Infiltration and Subsequent Photoreceptor Damage during Experimental Autoimmune Uveitis

Comparison of HIV- and EIAV-Based Vectors on Their Efficiency in Transducing Murine and Human Hematopoietic Repopulating Cells

Evolving Gene Therapy in Primary Immunodeficiency

Insertional Transformation of Hematopoietic Cells by Self-inactivating Lentiviral and Gammaretroviral Vectors

Gene Therapy of Chronic Granulomatous Disease: The Engraftment Dilemma

Predicting genotoxicity of viral vectors for stem cell gene therapy using gene expression-based machine learning

Preclinical Demonstration of Lentiviral Vector-mediated Correction of Immunological and Metabolic Abnormalities in Models of Adenosine Deaminase Deficiency

A Ubiquitous Chromatin Opening Element (UCOE) Confers Resistance to DNA Methylation–mediated Silencing of Lentiviral Vectors

Self-inactivating Gammaretroviral Vectors for Gene Therapy of X-linked Severe Combined Immunodeficiency

Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplant

A New Chapter on Targeted Gene Insertion for X-CGD: Do Not Skip the Intro(n)

Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-free Approach

Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-free Approach

Successful Reconstitution of Immunity in ADA-SCID by Stem Cell Gene Therapy Following Cessation of PEG-ADA and Use of Mild Preconditioning

Biochemical Correction of X-CGD by a Novel Chimeric Promoter Regulating High Levels of Transgene Expression in Myeloid Cells

Stable Gene Transfer to Muscle Using Non-integrating Lentiviral Vectors

Perforin Gene Transfer Into Hematopoietic Stem Cells Improves Immune Dysregulation in Murine Models of Perforin Deficiency

“Darwinian” Tumor-Suppression Model Unsupported in Clinical Experience

Correction of Murine Rag2 Severe Combined Immunodeficiency by Lentiviral Gene Therapy Using a Codon-optimized RAG2 Therapeutic Transgene

“Special Exemptions”: Should They Be Put on Trial?

Aktive Filter

Suchergebnisse filtern